and/or
520 News Items found
Q&A
Kenneth Marians and Louis V. Gerstner, Jr.
Reflecting on 15 Years of Leadership: An Interview with Outgoing GSK Dean Ken Marians
Meet the man who helped make the Gerstner Sloan Kettering Graduate School of Biomedical Sciences a reality.
In the News
Molecular biologist Ken Marians and cell biologist Michael Overholtzer
MSK’s Graduate School Welcomes New Dean, Bids Farewell to Its First
Cell biologist Michael Overholtzer will succeed DNA replication expert Ken Marians.
In the Lab
Different viewpoints of the STING pathway
Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments
Researchers are looking for ways to make cancer cells more visible to the immune system.
In the Lab
Sloan Kettering Institute molecular biologist Christine Mayr
Scientists Find Cancer Drivers Hiding in a New Place
New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
In the Lab
MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors
The engineered immune cells secrete powerful drugs as a layer of defense.
In the Lab
kratom leaves and pill
Kratom: What Research Tells Us about This Controversial Supplement for Pain Relief
Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.
In the Lab
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"
Targeting this signal with drugs might be one way to stop cancers from spreading.
Feature
MSK cell manufacturing specialist Xiuyan Wang
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity
A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
Feature
NK cells attacking
Meet the Unsung Immune Cell that Could Change Immunotherapy
A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.